Monashee Investment Management LLC Revance Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$14.33 - $28.47 $1.22 Million - $2.42 Million	85,000 New	85,000 $2.3 Million
Q1 2020 May 13, 2020	SELL	$12.46 - $27.81 $1.06 Million - $2.36 Million	-85,000 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$11.66 - $20.15 $991,100 - $1.71 Million	85,000 New	85,000 $1.38 Million
Q1 2018 May 10, 2018	SELL	$29.15 - $37.4 $2.04 Million - $2.62 Million	-70,000 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$24.55 - $36.3 $1.72 Million - $2.54 Million	70,000	70,000 $2.5 Million

231

83.2M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.